Full name
"BAMED" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,1 | -0,1 | -0,1 | -14,3 |
Gross profit (loss) | -0,3 | -0,5 | -0,6 | -27 |
EBITDA | -0,2 | -0,1 | -0,2 | -29,8 |
Short time liabilities | 5,6 | 6,4 | 7,3 | 14,4 |
Other operating costs | 0,1 | 0,1 | 0,1 | 38,8 |
Equity capital | -4,5 | -5 | -5,6 | -12,9 |
Operating profit (EBIT) | -0,2 | -0,1 | -0,2 | -27,6 |
Assets | 1,1 | 1,5 | 1,8 | 19,2 |
Net profit (loss) | -0,3 | -0,5 | -0,6 | -27 |
Cash | 0 | 0 | 0 | 19,3 |
Net income from sale | 5,8 | 6,6 | 7,5 | 13,6 |
Liabilities and provisions for liabilities | 5,6 | 6,5 | 7,4 | 14,4 |
Working assets | 1 | 1,3 | 1,6 | 22,3 |
Other income costs | 0 | 0 | 0 | 5,1 |
Depreciation | 0 | 0 | 0 | 3,9 |
% | % | % | p.p. | |
Profitability of capital | 6,5 | 10,2 | 11,4 | 1,2 |
Equity capital to total assets | -396,9 | -331,4 | -313,8 | 17,6 |
Gross profit margin | -5 | -7,7 | -8,6 | -0,9 |
EBITDA Margin | -3,2 | -2 | -2,3 | -0,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 352 | 357 | 359 | 2 |
Current financial liquidity indicator | 0.17080532014369965 | 0.2057812362909317 | 0.2200750857591629 | 0 |
Net dept to EBITDA | 0.12131789326667786 | 0.2062806785106659 | 0.18955011665821075 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane